The Next Wave After Immunotherapy in Cancer Drug Development—Back to the Future

This Viewpoint discusses the history of immunotherapy and the future of targeted therapy to treat cancer.

Authors

Satya N. Das (ORCID: https://orcid.org/0000-0002-1659-2499)

Institutions

Therapeutics Clinical Research (US)

Publication Details

Journal: JAMA Oncology
Published: 2025-05-22
DOI: https://doi.org/10.1001/jamaoncol.2025.0720
Citations: 1
Primary Topic: Cancer Immunotherapy and Biomarkers
Type: article
Field-Weighted Citation Impact: 1.05

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

The Next Wave After Immunotherapy in Cancer Drug Development—Back to the Future

Satya N. Das

May 22, 2025

1 citations

JAMA Oncology

Cancer Immunotherapy and Biomarkers

1.05

article

The Next Wave After Immunotherapy in Cancer Drug Development—Back to the Future

Satya N. Das

May 22, 2025article en

1 citations

Abstract

This Viewpoint discusses the history of immunotherapy and the future of targeted therapy to treat cancer.

JAMA OncologyVol. 11(7)

Therapeutics Clinical Research (US)

Good health and well-being

Openalex Percentile: Top 22%

Cancer Immunotherapy and Biomarkers

1.05

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The Next Wave After Immunotherapy in Cancer Drug Development—Back to the Future — Satya N. Das · JAMA Oncology (2025) | TGRS Research Map | TGRS